Among the non-AMKL patients, 22 expressed at least one megakaryocytic marker; CD42a.CD61 was positive in 11/114 (10%), CD41 in 15/114 (13%) and CD42b in 4/114 (4%) cases. Here, GP9 is linked to acute megakaryoblastic leukemia.